Palantir Lifts, Chips Slip in Analyst Reshuffle
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Analysts revised targets across a broad range of names on August 4. Palantir Technologies led the upgrades. The consensus target price rose to $185.68 from $182.20. Six analysts now rate it a Buy. The stock carries short interest of just 3.3% of free float — bears have little grip.
The semiconductor space drew more cautious calls. ON Semiconductor saw its average target trimmed to $112.29 from $113.63. All 18 covering analysts hold a Hold rating. Short interest sits at 8.0% of free float, reflecting ongoing concern about the chip cycle.
Fair Isaac faced a target cut too. The average dropped to $1,489 from $1,497. Fifteen analysts rate the stock a Sell. Short interest stands at 10.3% of free float — among the higher readings in the large-cap space.
On the positive side, Welltower and Vertex Pharmaceuticals both received target increases. Welltower's consensus target climbed to $255.59. Vertex's rose to $558.54, with 23 analysts rating it a Buy.
Diamondback Energy also attracted a target upgrade to $230.54. All 25 covering analysts maintain a Buy — one of the cleanest bullish consensus reads of the day.
Stocks in this article
How this article was generated
- Generated
- 4 Aug 2026, 04:20
- Prompt version
- v1.0
- Data sources
- Analyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.